Cantor Fitzgerald Sticks to Its Buy Rating for X4 Pharmaceuticals (XFOR)
Cantor Fitzgerald analyst Kristen Kluska maintained a Buy rating on X4 Pharmaceuticals (XFOR – Research Report) on January 14 and set a price ...
Intra-Cellular Therapies (NASDAQ:ITCI) Upgraded to “Strong-Buy” at Cantor Fitzgerald
Intra-Cellular Therapies (NASDAQ:ITCI – Get Free Report) was upgraded by equities research analysts at Cantor Fitzgerald from ...
Cantor Fitzgerald Sticks to Their Buy Rating for Amicus (FOLD)
In a report released yesterday, Kristen Kluska from Cantor Fitzgerald maintained a Buy rating on Amicus (FOLD – Research Report), with a price ...
Hosted on MSN2d
Cantor Fitzgerald Initiates Coverage of Camtek (CAMT) with Neutral Recommendation
Fintel reports that on January 13, 2025, Cantor Fitzgerald initiated coverage of Camtek (NasdaqGM:CAMT) with a Neutral ...
Fintel on MSN2d
Cantor Fitzgerald Initiates Coverage of Onto Innovation (ONTO) with Overweight Recommendation
Fintel reports that on January 13, 2025, Cantor Fitzgerald initiated coverage of Onto Innovation (NYSE:ONTO) with a ...
NBC Washington1mon
SEC charges Cantor Fitzgerald, led by Trump's Commerce pick, with breaking securities laws
The Securities and Exchange Commission charged Cantor Fitzgerald with violating laws related to disclosures by so-called blank-check companies before they raise money from the public. Cantor ...
Benzinga.com1mon
Financial Crime Weekly: Cantor Fitzgerald Charged With Violating AntiFraud Provisions, Ex-ComTech CEO Charged With Insider Trading
Cantor Fitzgerald is charged with violating antifraud and proxy provisions. Former Comtech CEO is charged with insider trading ahead of negative earnings. The Securities and Exchange Commission on ...
Reuters1mon
Cantor Fitzgerald pays $6.75 million to settle SEC charges over misleading SPAC disclosures
WASHINGTON, Dec 12 (Reuters) - Wall Street brokerage Cantor Fitzgerald has agreed to pay a $6.75 million penalty to settle Securities and Exchange Commission charges that it misled investors in ...
Morningstar1mon
Cantor Fitzgerald Large Cap Fcs Cl A
Cantor Fitzgerald Large Cap Focused Fund earns an Above Average Process Pillar rating. The most substantial contributor to the rating is the parent firm's five-year risk-adjusted success ratio of 90%.
Voyager Therapeutics (NASDAQ:VYGR) Coverage Initiated by Analysts at Cantor Fitzgerald
Cantor Fitzgerald assumed coverage on shares of Voyager Therapeutics (NASDAQ:VYGR – Free Report) in a research note published on Friday morning, Marketbeat reports. The firm issued an overweight ...
Yahoo Finance22d
Cantor Fitzgerald bullish on Avita Medical after FDA approval for RECELL GO Mini
Cantor Fitzgerald reiterates an Overweight rating on Avita Medical (RCEL) following the company receiving FDA premarket approval for RECELL GO Mini, its miniaturized device designed to treat ...
Morningstar1mon
Cantor Fitzgerald International Eq F
Cantor Fitzgerald International Eq Fund earns an Above Average Process Pillar rating. The primary contributor to the rating is the parent firm's five-year risk-adjusted success ratio of 90%.